The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial ; volume:6 ; number:4 ; day:21 ; month:7 ; year:2014 ; pages:1-9 ; date:8.2014
Alzheimer's research & therapy ; 6, Heft 4 (21.7.2014), 1-9, 8.2014

Creator: Prins, Niels D.

Contributor: van der Flier, Wiesje A.
Knol, Dirk L.
Fox, Nick C.
Brashear, H Robert
Nye, Jeffrey S.
Barkhof, Frederik
Scheltens, Philip
SpringerLink (Online service)

DOI: 10.1186/alzrt275

URN: urn:nbn:de:1111-2016073131901

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Prins, Niels D.
van der Flier, Wiesje A.
Knol, Dirk L.
Fox, Nick C.
Brashear, H Robert
Nye, Jeffrey S.
Barkhof, Frederik
Scheltens, Philip
SpringerLink (Online service)

Other Objects (12)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

The “rights” of precision drug development for Alzheimer’s disease

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

The “rights” of precision drug development for Alzheimer’s disease

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

The “rights” of precision drug development for Alzheimer’s disease

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

The “rights” of precision drug development for Alzheimer’s disease

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

The “rights” of precision drug development for Alzheimer’s disease

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

The “rights” of precision drug development for Alzheimer’s disease

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Related objects

Reset password